Temat: "Pancreatic Neoplasms" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Pancreatic Cancer: A Review of Current Treatment and Novel Therapies.
Autorzy:: Kolbeinsson HM; Spectrum Health General Surgery Residency, Grand Rapids, Michigan, USA.; Department of Surgery, Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA.
Chandana S; Department of Surgery, Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA.; Cancer and Hematology Centers of Western Michigan, PC, Grand Rapids, Michigan, USA.
Wright GP; Spectrum Health General Surgery Residency, Grand Rapids, Michigan, USA.; Department of Surgery, Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA.; Division of Surgical Oncology, Spectrum Health Medical Group, Grand Rapids, Michigan, USA.
Chung M; Spectrum Health General Surgery Residency, Grand Rapids, Michigan, USA.; Department of Surgery, Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA.; Division of Surgical Oncology, Spectrum Health Medical Group, Grand Rapids, Michigan, USA.; Pokaż więcej
Źródło:: Journal of investigative surgery : the official journal of the Academy of Surgical Research [J Invest Surg] 2023 Dec 31; Vol. 36 (1), pp. 2129884. Date of Electronic Publication: 2022 Oct 03.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Pancreatic Neoplasms*/therapy
Pancreatic Neoplasms*/drug therapy
Antineoplastic Agents*/therapeutic use
Humans ; United States ; Combined Modality Therapy ; Neoadjuvant Therapy ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial.
Autorzy:: Augustinus S; Amsterdam UMC, Department of Surgery, University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Broekman T; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Department of Medical Oncology, University of Amsterdam, Amsterdam, The Netherlands.
Creemers GJ; Department of Medical Oncology, Catherina Hospital, Eindhoven, The Netherlands.
Daamen LA; Division of Imaging & Oncology, University Medical Center Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.; Department of Surgery, University Medical Center Utrecht Cancer Center, St Antonius Hospital Nieuwegein, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
van Dieren S; Amsterdam UMC, Department of Surgery, University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
de Groot JB; Department of Medical Oncology, Oncology Center Isala, Zwolle, The Netherlands.
Cirkel GA; Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Meander Medisch Centrum, Amersfoort, The Netherlands.
Homs MYV; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.
van Laarhoven HWM; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Department of Medical Oncology, University of Amsterdam, Amsterdam, The Netherlands.
van Leeuwen L; Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Diakonessenhuis, Utrecht, The Netherlands.
Los M; Department of Medical Oncology, Regional Academic Cancer Center Utrecht, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands.
Luelmo SAC; Department of Medical Oncology, Leids Universitair Medisch Centrum, Leiden, The Netherlands.
van Oijen MGH; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Department of Medical Oncology, University of Amsterdam, Amsterdam, The Netherlands.
Spierings LEAM; Department of Medical Oncology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands.
de Vos-Geelen J; Department of Medical Oncology, GROW, Maastricht UMC, Maastsricht, The Netherlands.
Besselink MG; Amsterdam UMC, Department of Surgery, University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Wilmink JW; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Department of Medical Oncology, University of Amsterdam, Amsterdam, The Netherlands.; Pokaż więcej
Corporate Authors:: Dutch Pancreatic Cancer Group
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1973-1978. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:: Journal Article
MeSH Terms:: Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/pathology
Patient Preference*
Humans ; Multicenter Studies as Topic ; Pancreas/pathology ; Prospective Studies ; Clinical Trials as Topic ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
Autorzy:: Zheng Q; Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tang J; Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Aicher A; Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Immunology Research and Development Center, China Medical University, Taichung, Taiwan.
Bou Kheir T; Barts Cancer Institute, Queen Mary University of London, London, UK.
Sabanovic B; Pancreatic Cancer Heterogeneity Lab, Candiolo Cancer Institute - FPO - IRCCS, Candiolo, Turin, Italy.
Ananthanarayanan P; Pancreatic Cancer Heterogeneity Lab, Candiolo Cancer Institute - FPO - IRCCS, Candiolo, Turin, Italy.
Reina C; Pancreatic Cancer Heterogeneity Lab, Candiolo Cancer Institute - FPO - IRCCS, Candiolo, Turin, Italy.
Chen M; Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gu JM; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
He B; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China.
Alcala S; Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Instituto de Investigaciones Biomédicas 'Alberto Sols' CSIC-UAM, Chronic Diseases and Cancer Area 3 Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain.
Behrens D; Experimental Pharmacology and Oncology Berlin-Buch GmbH, Berlin, Germany.
Lawlo RT; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.; ARC-Net, Applied Research On Cancer Centre, University of Verona, Verona, Italy.
Scarpa A; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.; ARC-Net, Applied Research On Cancer Centre, University of Verona, Verona, Italy.
Hidalgo M; Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Sainz B Jr; Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Instituto de Investigaciones Biomédicas 'Alberto Sols' CSIC-UAM, Chronic Diseases and Cancer Area 3 Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain.
Sancho P; IIS Aragon, Hospital Universitario Miguel Servet, 50009, Saragossa, Spain. .
Heeschen C; Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .; State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Pancreatic Cancer Heterogeneity Lab, Candiolo Cancer Institute - FPO - IRCCS, Candiolo, Turin, Italy. .; Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Nov 28; Vol. 42 (1), pp. 323. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:: Journal Article
MeSH Terms:: Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/genetics
Carcinoma, Pancreatic Ductal*/metabolism
Humans ; Animals ; Mice ; Signal Transduction ; Proto-Oncogene Proteins c-myc/genetics ; Proto-Oncogene Proteins c-myc/metabolism ; Cell Line, Tumor ; Neoplasm Recurrence, Local/pathology ; Neoplastic Stem Cells/metabolism ; Receptors, Cytoplasmic and Nuclear/metabolism ; SOXB1 Transcription Factors/genetics ; SOXB1 Transcription Factors/metabolism ; Pancreatic Neoplasms
SCR Disease Name:: Spinocerebellar Ataxia, Autosomal Recessive 2

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer.
Autorzy:: Zheng S; Department of Pancreas Center, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, Guangdong, China.
Tian Q; School of medicine, South China University of Technology, Guangzhou, 510006, Guangdong Province, China.
Yuan Y; Guangdong cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, Guangdong, China.
Sun S; Department of Pancreas Center, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, Guangdong, China.
Li T; School of medicine, South China University of Technology, Guangzhou, 510006, Guangdong Province, China.
Xia R; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China.
He R; Department of Pancreas Center, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, Guangdong, China.; Shantou University Medical College, Shantou, 515041, Guangdong province, China.
Luo Y; Department of Pancreas Center, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, Guangdong, China.
Lin Q; Department of Pancreas Center, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, Guangdong, China.
Fu Z; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, Guangdong, China.; Department of Pancreatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, Guangdong, China.
Zhou Y; Department of Pancreas Center, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, Guangdong, China. .
Chen R; Department of Pancreas Center, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, Guangdong, China. .; School of medicine, South China University of Technology, Guangzhou, 510006, Guangdong Province, China. .; Guangdong cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, Guangdong, China. .
Hu C; Department of Pancreas Center, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, Guangdong, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Nov 28; Vol. 42 (1), pp. 324. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:: Journal Article
MeSH Terms:: Cancer-Associated Fibroblasts*/metabolism
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/genetics
Carcinoma, Pancreatic Ductal*/metabolism
Extracellular Vesicles*/metabolism
Humans ; Platinum/pharmacology ; Oxaliplatin/pharmacology ; Oxaliplatin/therapeutic use ; Sumoylation ; RNA/metabolism ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
Autorzy:: Karbhari A; Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.
Mosessian S; Clinical Development, Sofie Biosciences, Dulles, Virginia, United States of America.
Trivedi KH; Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.
Valla F Jr; Radiopharmaceutical and Contract Manufacturing, Sofie Biosciences, Dulles, Virginia, United States of America.
Jacobson M; Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.
Truty MJ; Department of Surgery, Mayo Clinic, Rochester, Minnesota, United States of America.
Patnam NG; Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.
Simeone DM; Departments of Surgery and Pathology, NYU Langone Health, New York, New York, United States of America.
Zan E; Department of Radiology, Weill Cornell Medicine, New York, New York, United States of America.
Brennan T; Discovery Life Sciences, Newtown, Pennsylvania, United States of America.
Chen H; Discovery Life Sciences, Newtown, Pennsylvania, United States of America.
Kuo PH; Departments of Medical Imaging, Medicine and Biomedical Engineering, University of Arizona, Tucson, Arizona, United States of America.
Herrmann K; Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Goenka AH; Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Nov 27; Vol. 18 (11), pp. e0294564. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2023).
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/pathology
Adenocarcinoma*/drug therapy
Carcinoma, Pancreatic Ductal*/diagnostic imaging
Carcinoma, Pancreatic Ductal*/drug therapy
Adult ; Humans ; Gallium Radioisotopes ; Positron-Emission Tomography ; Fibroblasts/pathology ; Positron Emission Tomography Computed Tomography ; Fluorodeoxyglucose F18/therapeutic use ; Multicenter Studies as Topic ; Clinical Trials, Phase II as Topic ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a case report.
Autorzy:: Chan W; Irvine Department of Radiological Sciences, University of California, 101 The City Drive South, Orange, CA, 92868, USA.
Park S; Irvine Department of Radiological Sciences, University of California, 101 The City Drive South, Orange, CA, 92868, USA.
Shirkhoda L; Irvine Department of Radiological Sciences, University of California, 101 The City Drive South, Orange, CA, 92868, USA.
O'Connell R; Irvine Department of Pathology and Laboratory Medicine, School of Medicine, University of California, University of California Irvine, Irvine, CA, 92697, USA.
Houshyar R; Irvine Department of Radiological Sciences, University of California, 101 The City Drive South, Orange, CA, 92868, USA. .; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2023 Nov 16; Vol. 17 (1), pp. 477. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Carcinoma*/surgery
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/therapy
Pancreatic Neoplasms*/pathology
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/therapy
Adenocarcinoma*/pathology
Humans ; Male ; Middle Aged ; Osteoclasts/pathology ; Pancreas/pathology ; Giant Cells/pathology ; Disease Progression ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy.
Autorzy:: Du X; Key Laboratory of Structure-Based Drug Design and Discovery, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang, 110016, China.; State Key Laboratory of Toxicology and Medical Countermeasures, Institute of Pharmacology and Toxicology, Beijing, 100850, China.; Nanhu Laboratory, Jiaxing, 314002, China.
Yi X; State Key Laboratory of Proteomics, Institute of Basic Medical Sciences, National Center of Biomedical Analysis, Beijing, 100850, China.; Nanhu Laboratory, Jiaxing, 314002, China.
Zou X; Key Laboratory of Structure-Based Drug Design and Discovery, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang, 110016, China.; State Key Laboratory of Toxicology and Medical Countermeasures, Institute of Pharmacology and Toxicology, Beijing, 100850, China.
Chen Y; State Key Laboratory of Proteomics, Institute of Basic Medical Sciences, National Center of Biomedical Analysis, Beijing, 100850, China.; Nanhu Laboratory, Jiaxing, 314002, China.
Tai Y; Department of Pathology, No.307 Hospital of PLA, Beijing, 100071, China.
Ren X; Key Laboratory of Structure-Based Drug Design and Discovery, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang, 110016, China. .
He X; State Key Laboratory of Toxicology and Medical Countermeasures, Institute of Pharmacology and Toxicology, Beijing, 100850, China. .; Nanhu Laboratory, Jiaxing, 314002, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Nov 13; Vol. 23 (1), pp. 1102. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma*
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Humans ; Prognosis ; Flutamide ; RNA ; Biomarkers ; Gene Expression Regulation, Neoplastic ; Protocadherins ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: An integrated study to decipher immunosuppressive cellular communication in the PDAC environment.
Autorzy:: Avşar G; Department of Bioengineering, Gebze Technical University, Kocaeli, Turkey. .; Turkish Academy of Sciences, Ankara, Turkey. .
Pir P; Department of Bioengineering, Gebze Technical University, Kocaeli, Turkey.; Pokaż więcej
Źródło:: NPJ systems biology and applications [NPJ Syst Biol Appl] 2023 Nov 10; Vol. 9 (1), pp. 56. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:: Journal Article
MeSH Terms:: Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
Pancreatic Neoplasms*/pathology
Carcinoma, Pancreatic Ductal*/genetics
Carcinoma, Pancreatic Ductal*/metabolism
Carcinoma, Pancreatic Ductal*/pathology
Humans ; Communication ; Tumor Microenvironment/genetics ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer.
Autorzy:: Li L; Faculty of Hepato-Pancreato-Biliary Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, China.; Department of Surgery, Second Mobile Corps Hospital of Chinese People's Armed Police Force, Wuxi, China.
Wang F; Faculty of Hepato-Pancreato-Biliary Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Deng Z; Faculty of Hepato-Pancreato-Biliary Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Zhang G; Faculty of Hepato-Pancreato-Biliary Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Zhu L; Faculty of Hepato-Pancreato-Biliary Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Zhao Z; Faculty of Hepato-Pancreato-Biliary Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, China. .
Liu R; Faculty of Hepato-Pancreato-Biliary Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Nov 07; Vol. 23 (1), pp. 1073. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplastic Processes*
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/therapy
Humans ; Cell Transformation, Neoplastic ; Carcinogenesis ; Methyltransferases/genetics ; Exodeoxyribonucleases ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Incidence and risk of pancreatic cancer in patients with acute or chronic pancreatitis: a population-based cohort study.
Autorzy:: Park SM; Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.; Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea.
Kim KB; Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.; Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea.
Han JH; Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.; Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea.
Kim N; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Bundang Hospital, Seungnam, Republic of Korea.
Kang TU; Health and Wellness College, Sungshin Women's University, Seoul, Republic of Korea.
Swan H; Department of Preventive Medicine, Korea University College of Medicine, 126-1, 5-ga, Inchon-ro, Seoul, 136-705, Republic of Korea.
Kim HJ; Department of Preventive Medicine, Korea University College of Medicine, 126-1, 5-ga, Inchon-ro, Seoul, 136-705, Republic of Korea. .; Department of Public Health, Graduate School, Korea University, Seoul, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 02; Vol. 13 (1), pp. 18930. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Pancreatitis, Chronic*/complications
Pancreatitis, Chronic*/epidemiology
Pancreatic Neoplasms*/epidemiology
Pancreatic Neoplasms*/complications
Male ; Female ; Humans ; Incidence ; Cohort Studies ; Acute Disease ; Risk Factors ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Hedgehog-Gli1-derived exosomal circ-0011536 mediates peripheral neural remodeling in pancreatic cancer by modulating the miR-451a/VGF axis.
Autorzy:: Dai W; Department of Gastroenterology, Shidong Hospital of Shanghai, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, No. 999, Shiguang Road, Yangpu District, Shanghai, China.
Wu X; Department of Gastroenterology, Shidong Hospital of Shanghai, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, No. 999, Shiguang Road, Yangpu District, Shanghai, China.; Chongqing General Hospital, Chongqing, China.
Li J; Department of Gastroenterology, Shidong Hospital of Shanghai, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, No. 999, Shiguang Road, Yangpu District, Shanghai, China.
Tang W; West China Xiamen Hospital of Sichuan University, Xiamen, Fujian Province, China.
Wang Y; The People's Hospital of Pizhou, Xuzhou, Jiangsu Province, China.
Xu W; Department of Gastroenterology, Shidong Hospital of Shanghai, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, No. 999, Shiguang Road, Yangpu District, Shanghai, China.
Han D; Department of Gastroenterology, Shidong Hospital of Shanghai, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, No. 999, Shiguang Road, Yangpu District, Shanghai, China.
Xu X; Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301, Yanchang Road, Jingan District, Shanghai, China. .
Xu X; Department of Gastroenterology, Shidong Hospital of Shanghai, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, No. 999, Shiguang Road, Yangpu District, Shanghai, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Dec 02; Vol. 42 (1), pp. 329. Date of Electronic Publication: 2023 Dec 02.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Pancreatic Neoplasms*/pathology
Carcinoma, Pancreatic Ductal*/pathology
Humans ; Mice ; Animals ; Hedgehog Proteins/genetics ; Zinc Finger Protein GLI1/genetics ; Cell Proliferation ; Cell Line, Tumor ; Nerve Growth Factors ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer.
Autorzy:: Chang CD; Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Chao MW; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.; Institute of Biopharmaceutical Sciences, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
Lee HY; Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.
Liu YT; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Tu HJ; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Lien ST; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Lin TE; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Sung TY; Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan.
Yen SC; Warshel Institute for Computational Biology, The Chinese University of Hong Kong (Shenzhen), Shenzhen, Guangdong, People's Republic of China.
Huang SH; Graphen Inc, New York, NY, USA.
Hsu KC; Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; TMU Research Center for Drug Discovery, Taipei Medical University, Taipei, Taiwan.; Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Pan SL; Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; TMU Research Center for Drug Discovery, Taipei Medical University, Taipei, Taiwan.; Pokaż więcej
Źródło:: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2023 Dec; Vol. 38 (1), pp. 2166039.
Typ publikacji:: Journal Article
MeSH Terms:: Pancreatic Neoplasms*/enzymology
Protein Serine-Threonine Kinases*/antagonists & inhibitors
Protein Kinase Inhibitors*/chemistry
Protein Kinase Inhibitors*/pharmacology
Antineoplastic Agents*/chemistry
Antineoplastic Agents*/pharmacology
Humans ; Cell Line, Tumor ; Gemcitabine/chemistry ; Gemcitabine/pharmacology ; Intracellular Signaling Peptides and Proteins ; Computer Simulation ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Study on tumour cell-derived hybrid exosomes as dasatinib nanocarriers for pancreatic cancer therapy.
Autorzy:: Zhou X; Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.; Department of Clinical Research Center, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Zhuang Y; Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Liu X; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Gu Y; Institute of Medical Information/Library, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Department of Chemistry, NY University, New York City, NY, USA.
Wang J; Beijing Institute of Radiation Medicine, Beijing, China.
Shi Y; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Zhang L; Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Li R; Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Zhao Y; Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Chen H; Beijing Institute of Radiation Medicine, Beijing, China.
Li J; Institute of Medical Information/Library, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Yao H; Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Li L; Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.; Pokaż więcej
Źródło:: Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2023 Dec; Vol. 51 (1), pp. 532-546. Date of Electronic Publication: 2023 Oct 05.
Typ publikacji:: Journal Article
MeSH Terms:: Exosomes*/metabolism
Pancreatic Neoplasms*/pathology
Carcinoma, Pancreatic Ductal*/metabolism
Carcinoma, Pancreatic Ductal*/pathology
Humans ; Dasatinib/pharmacology ; Dasatinib/metabolism ; Cell Line, Tumor ; Liposomes/metabolism ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors.
Autorzy:: Yang B; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Quan Y; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Zhao W; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Ji Y; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Yang X; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Li J; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Li Y; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Liu X; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Wang Y; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Li Y; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.; Pokaż więcej
Źródło:: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2023 Dec; Vol. 38 (1), pp. 2169282.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents*/pharmacology
Pancreatic Neoplasms*/drug therapy
Humans ; Mice ; Animals ; Cell Line, Tumor ; Cell Cycle Checkpoints ; Protein Kinase Inhibitors/pharmacology ; Cell Proliferation ; Apoptosis ; Pyrimidines/pharmacology ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Expression of miR-425-5p in Pancreatic Carcinoma and Its Correlation with Tumor Immune Microenvironment.
Autorzy:: Jian S; Department of Oncology, Suining Central Hospital, Suining, Sichuan Province, China.
Kong D; Department of Oncology, Suining Central Hospital, Suining, Sichuan Province, China.
Tian J; Department of Oncology, Suining Central Hospital, Suining, Sichuan Province, China.; Pokaż więcej
Źródło:: Journal of investigative surgery : the official journal of the Academy of Surgical Research [J Invest Surg] 2023 Dec; Vol. 36 (1), pp. 2216756.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Pancreatic Neoplasms*/genetics
Humans ; Interleukin-10 ; Interleukin-2 ; Transforming Growth Factor beta ; Cell Line, Tumor ; Cell Proliferation ; Tumor Microenvironment ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
Autorzy:: Huang Y; Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Gong P; Internal Medicine Department of Oncology, Anhui Wannan Rehabilitation Hospital (The Fifth People's Hospital of Wuhu), Wuhu, China.
Su L; Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhang M; Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 27; Vol. 13 (1), pp. 20870. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma*/genetics
Pancreatic Neoplasms*/genetics
RNA, Long Noncoding*/genetics
Humans ; CD8-Positive T-Lymphocytes ; Pancreatic Neoplasms ; Prognosis ; Tumor Microenvironment/genetics ; Apoptosis ; Copper

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Pan-Inhibition of Protein Disulfide Isomerase Caused Cell Death through Disrupting Cellular Proteostasis in Pancreatic Ductal Adenocarcinoma Cells.
Autorzy:: Hung CS; Department of Laboratory Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Lee KL; Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Huang WJ; Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
Su FH; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Liang YC; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.; Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.; Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.; Traditional Herbal Medicine Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 17; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:: Journal Article
MeSH Terms:: Pancreatic Neoplasms*
Carcinoma, Pancreatic Ductal*/drug therapy
Humans ; Protein Disulfide-Isomerases ; Proteostasis ; Endoplasmic Reticulum Stress ; Apoptosis ; Autophagy ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.
Autorzy:: Xu Q; Department of Hepatobiliary surgery, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515041, China.
Zheng J; Department of pharmacy, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515041, China.
Su Z; Department of anesthesiology, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515041, China.
Chen B; Department of Hepatobiliary surgery, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515041, China.
Gu S; Department of Hepatobiliary surgery, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515041, China. .; Pokaż więcej
Źródło:: BMC gastroenterology [BMC Gastroenterol] 2023 Nov 16; Vol. 23 (1), pp. 397. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma*/genetics
Pancreatic Neoplasms*/genetics
Humans ; B7 Antigens ; Biomarkers ; Carcinogenesis/genetics ; Cell Transformation, Neoplastic ; Gene Expression Regulation, Neoplastic ; Prognosis ; Transcription Factors ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Detection of HHV-6 Virus in specimen of a ductal pancreatic adenocarcinoma with comparison in tumor and normal tissue.
Autorzy:: Warkentin S; RWTH Aachen University DE, Aachen, Germany.
Braunschweig TA; RWTH Aachen University DE, Aachen, Germany.
Jonigk D; RWTH Aachen University DE, Aachen, Germany.
Losen I; RWTH Aachen University DE, Aachen, Germany.
Cassataro MA; RWTH Aachen University DE, Aachen, Germany.
Kleines M; RWTH Aachen University DE, Aachen, Germany. .; Pokaż więcej
Źródło:: Diagnostic pathology [Diagn Pathol] 2023 Nov 14; Vol. 18 (1), pp. 124. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:: Journal Article
MeSH Terms:: Herpesvirus 6, Human*/genetics
Adenocarcinoma*
Roseolovirus Infections*/diagnosis
Roseolovirus Infections*/genetics
Pancreatic Neoplasms*
Carcinoma, Pancreatic Ductal*
Humans ; DNA, Viral/genetics ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis.
Autorzy:: Stoecklein NH; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. .
Fluegen G; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Guglielmi R; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Neves RPL; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Hackert T; Department of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Birgin E; Department of Surgery, Medical Faculty Mannheim, University Hospital Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Cieslik SA; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Sudarsanam M; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Driemel C; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
van Dalum G; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Franken A; Department of Obstetrics and Gynecology, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Niederacher D; Department of Obstetrics and Gynecology, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Neubauer H; Department of Obstetrics and Gynecology, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Fehm T; Department of Obstetrics and Gynecology, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Rox JM; Department of Transplantation Diagnostics and Cell Therapeutics, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Böhme P; Institute of Forensic Medicine Düsseldorf, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Häberle L; Institute of Pathology, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Göring W; Institute of Pathology, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Esposito I; Institute of Pathology, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Topp SA; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Coumans FAW; Decisive Science, Ertskade 10, 1019 BB, Amsterdam, The Netherlands.; Current Affiliation: Department for General and Visceral Surgery, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
Weitz J; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Knoefel WT; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Fischer JC; Department of Transplantation Diagnostics and Cell Therapeutics, University Hospital and Medical Faculty of the Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Bork U; Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus of the Technical University Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
Rahbari NN; Department of Surgery, Medical Faculty Mannheim, University Hospital Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. .; Current Affiliation: Department for General and Visceral Surgery, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2023 Nov 13; Vol. 22 (1), pp. 181. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Pancreatic Neoplasms*/diagnosis
Adenocarcinoma*/diagnosis
Neoplastic Cells, Circulating*/pathology
Humans ; Liquid Biopsy/methods ; Biomarkers, Tumor ; Blood Volume ; Pancreatic Neoplasms

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Pancreatic Neoplasms"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język